EUCTR2007-006069-34-IT进行中（未招募）不适用
Clinical efficacy and cell mobilization activity of pegfilgrastim in patients with gynaecological malignancies in therapy with topotecan. - ND
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI0 个研究点开始时间: 2007年11月9日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Patients with advanced gynaecological malignancies who undergo salvage-chemotherapy with topotecan and prophylaxis of febrile neutropenia with GCSF according to the NCCN-2005 guidelines (6) are enrolled in the present study. In particular, the following patient populations are administered with standard-dose topotecan: i) ovarian cancer patients with disease progression after 1st line chemotherapy (carboplatin and taxol) followed by 2nd and 3rd line treatments (i.e. antracyclines). ii) endometrial or cervical cancer patients, eventually treated with radiotherapy, with disease progression after 2 lines of chemotherapy.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •leucemy, AML Pregnancy
研究者
相似试验
已完成
不适用
Cellular effects and clinical effectiveness of currently prescribed doses of carbamide peroxide tooth whitening productsISRCTN32619484Record Provided by the NHSTCT Register - 2006 Update - Department of Health30
招募中
2 期
Effect of Cell Therapy on knee Osteoarthritisostheoarthritis.Osteoarthritis of kneeIRCT20180102038184N1Oroumia University of Medical Sciences5
已完成
2 期
se of atorvastatin in bone marrow transplantatioFollicular lymphomaCondition 1: Follicular lymphoma. Condition 2: Hodgkin lymphoma. Condition 3: Non-follicular lymphoma. Condition 4: Multiple myeloma and malignant plasma cell neoplasms.Non-follicular lymphomaMultiple myeloma and malignant plasma cell neoplasmsHodgkin lymphomaIRCT2014071418484N1Vice Chancellor for Research, Tehran University of Medical Sciences44
招募中
不适用
earned pharmacological responses on cell proliferation: Inhibiting the mTOR-signaling pathwayhealthy male participantsDRKS00017020niversitätsklinikum Essen80
尚未招募
1 期
Tumor-infiltrating Lymphocytes therapy in Breast CancerIRCT20140818018842N34Tehran University of Medical Sciences10